Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Seer, Inc. - Class A Common Stock
(NQ:
SEER
)
1.745
+0.065 (+3.87%)
Streaming Delayed Price
Updated: 2:22 PM EDT, May 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seer, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025
October 10, 2025
Scientific presentations reveal how Seer’s Proteograph Product Suite is a critical component of multi-omic translational studies and enables profiling of protein isoform-specific biomarkers
From
Seer, Inc.
Via
GlobeNewswire
Seer Appoints Isaac Ro to its Board of Directors
September 02, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 26, 2025
From
Seer, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Seer to Participate in Upcoming November Investor Conferences
October 29, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Third Quarter 2025 Financial Results on November 6, 2025
October 16, 2025
From
Seer, Inc.
Via
GlobeNewswire
RetinalGenix Technologies Contracts with Seer Bio to Explore Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 16, 2025
From
RetinalGeniX Technologies, Inc.
Via
GlobeNewswire
Seer (SEER) Q2 Revenue Jumps 32%
↗
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
Seer (SEER) Q2 2025 Earnings Call Transcript
↗
August 06, 2025
Via
The Motley Fool
Topics
Earnings
World Trade
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
August 06, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 31, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
July 22, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
June 01, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
May 29, 2025
From
Seer, Inc.
Via
GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
May 14, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
May 13, 2025
Revenue grew 37%, driven by increased product sales and service revenue
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
April 24, 2025
From
Seer, Inc.
Via
GlobeNewswire
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
February 27, 2025
Validated technology with exceptional growth of customer publications and enhanced access to the Proteograph Product Suite with growing demand for Seer Technology Access Center (STAC)
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
February 21, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 13, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
February 20, 2025
Seminar from Dr. Jinjun Shi from Brigham and Women's Hospital and Harvard Medical School to highlight study of proteomic perturbations resulting from a novel approach to cancer therapy revealed using...
From
Seer, Inc.
Via
GlobeNewswire
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
January 02, 2025
From
Seer, Inc.
Via
GlobeNewswire
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
November 21, 2024
Attributes 2,440% revenue growth to increased adoption of its Proteograph™ Product Suite and exciting discoveries made by Seer customers across multiple areas of biology and disease
From
Seer, Inc.
Via
GlobeNewswire
Seer to Participate in Upcoming November Investor Conferences
November 08, 2024
From
Seer, Inc.
Via
GlobeNewswire
Seer Reports Third Quarter 2024 Financial Results
November 06, 2024
Growing enthusiasm for Proteograph Product Suite with multiple larger orders from government agencies and continued strong interest in STAC
From
Seer, Inc.
Via
GlobeNewswire
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
November 06, 2024
Collaboration enhances unprecedented access to deep, unbiased proteomics at scale, enabling deeper insights into human biology
From
Seer, Inc.
Via
GlobeNewswire
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
October 31, 2024
CoLab session with PrognomiQ and Salk Institute plus multiple presentations of new data offer firsthand look at multi-omic breakthroughs powered by Seer’s Proteograph™ Product Suite
From
Seer, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
